Today on DrugResearcher.com   No embryo required: human stem cells from the skin Cisbio licenses 'universal' kinase assay platform Covance rescues Eli Lilly's forgotten facility Evolution study finds 300 new genes Men get the heads up on possible oral contraceptive

Related Industry News   Pharmaceutical manufacturing: people on the move Covance rescues Eli Lilly's forgotten facility Biovail knocked back by FDA decision Blast at Aesica London plant

Breaking News on Drug Discovery
Daily  Wednesday 21 November 2007		Forward to a colleague

	Sponsored Link ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma... Read Cisbio licenses 'universal' kinase assay platform Cisbio has licensed BellBrook Labs' ADP immunodetection technology for use in its HTRF screening system that will enable researchers to study the activity of any protein kinase... Read Covance rescues Eli Lilly's forgotten facility Covance has acquired a partially constructed facility from Eli Lilly and plans to invest $175m (€118m) to convert it into a drug development laboratory to meet demand from its biopharmaceutical customers... Read Evolution study finds 300 new genes A supercomputer designed to root out genes that have been conserved over millions of years of evolution has discovered 300 new human genes... Read Men get the heads up on possible oral contraceptive It might be years away yet, but men could be the ones popping a pill for contraception if GTx has anything to do with it... Read
	All News Headlines for: November | October | September
	Product Presentation ZIC®-HILIC Separation of Polar and Hydrophilic Compounds The technology leading ZIC®HILIC and ZIC®-pHILIC separation media, designed for polar and hydrophilic compounds, are tools for clinical analysis and to solve separation and purification problems in research, development and production of pharmaceuticals. ZIC®-HILIC... Click Here
	Related Industry News Pharmaceutical manufacturing: people on the move Alfacell, Phoqus Pharmaceuticals, Watson Pharmaceuticals, Stem Cell Sciences, Kythera Biopharmaceuticals and ISPE have all had people on the move in the world of pharmaceutical manufacturing... Read Covance rescues Eli Lilly's forgotten facility Covance has acquired a partially constructed facility from Eli Lilly and plans to invest $175m (€118m) to convert it into a drug development laboratory to meet demand from its biopharmaceutical customers... Read Biovail knocked back by FDA decision Canadian firm Biovail has been thrown another curveball by US regulators as the resubmission for its antidepressant candidate is handed Class 2 status, delaying approval for at least another six months... Read Blast at Aesica London plant Contract manufacturer Aesica has confirmed reports of a blast at its Ponders End facility in North London last night, hospitalising three workers... Read Weekly Comment FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines Cancer antibody marches on quoths Raven Biotechnologies Raven Biotechnologies have announced positive initial clinical trial results for their anticancer antibody that causes tumour cells to swell up and die... Read Cystatin C can wash away Alzheimer's plaques Scientists have discovered that a protein called cystatin C can prevent damaging Alzheimer's plaques from forming by keeping their constituent protein water soluble... Read Simultaneous measurement of multiple cytokines Researchers at Randox, UK, have developed a biochip that enables the simultaneous measurement of 12 human cytokines from human serum samples enabling cytokine studies to be conducted faster... Read Merck turns to India for latest R&D partnership Merck & Co. has turned to India's Nicholas Piramal (NPIL) for its latest research collaboration, as the preclinical offshoring trend persists... Read Kids' vaccine market set to quadruple A recent report suggests that the market for paediatric and adolescent vaccines is set to grow four-fold over the next decade, spearheaded by Wyeth's Prevnar as the first blockbuster vaccine... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com